Remove 2019 Remove Diagnosis Remove Manufacturing Remove Provider
article thumbnail

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

For dentists, it’s transforming diagnosis, decision-making, and treatment planning. Researchers in 2019 developed a machine learning method to accurately quantify immune cells in the vicinity of oral cancer cells. For patients, it promises more accurate care and better outcomes. And there are so many such devices on the market.

Patients 126
article thumbnail

CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes

FDA Law Blog

CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. Remarkably, manufacturers may not dispute a CMS notification.

article thumbnail

CMS Publishes Grab Bag of Proposed Changes to the Medicaid Drug Rebate Program

FDA Law Blog

Most are new or revised definitions and administrative changes, but several proposals represent new policies that should be of concern to drug manufacturers. Price Transparency Surveys The MDRP statute requires manufacturers to submit only three prices: average manufacturer price (AMP), best price, and nominal prices.